Author: healthadmin

A large clinical trial suggests that taking a daily multivitamin may help slow biological aging in older people, especially those whose bodies were aging faster than expected at the start of the study. Researchers at Massachusetts General Brigham analyzed data from older adults who participated in randomized clinical trials and found that two years of multivitamin use was associated with slower biological aging based on several DNA-based measurements. This effect was equivalent to an approximately 4-month reduction in biological aging over the study period. The survey results are natural medicine. “Today, there is a lot of interest in identifying ways…

Increasing bone density does not prevent fractures in patients with a rare genetic disorder that causes bones to break easily, a large clinical trial has found. Patients with brittle bone disease who received treatment to increase bone density experienced a similar number of fractures as patients who received standard treatment. The findings cast doubt on the long-held idea that better bone density may help people with the disease, and suggest that treatment strategies should instead focus on improving bone quality, experts say. Brittle bone disease, or osteogenesis imperfecta (OI), is caused by defects in the production of collagen, a protein…

New research published in journal neuron This provides evidence that the brain stores competing memories about alcohol use and recovery in different networks of the same type of brain cells. This study suggests that memories that encourage a return to drinking and memories that inhibit it exist side by side, competing to control a person’s behavior. These findings provide a nuanced understanding of how addiction persists and suggest potential new ways to improve the treatment of alcohol use disorders. Addiction occurs when an addictive substance hijacks normal learning processes, leading to the formation of powerful memories that associate certain behaviors…

Chromie Health, an artificial intelligence hospital operations platform, has raised $2 million in pre-seed funding in parallel with the launch of its flagship SMS AI-driven staffing agency, Chromie Dispatch. AIX Ventures led the pre-seed round. AIX Ventures partner Krish Ramadurai said in a statement that the company is “building an AI agent layer for hospitals.” “By tackling department-level disruption with a true no-code, SMS-based solution, Chromie is poised to unlock billions in value across the healthcare system,” said Ramadurai. Douglas Ford, CEO and co-founder of Chromie Health, told Fierce Healthcare that the company is growing rapidly due to customer and…

Researchers at Stanford University School of Medicine have discovered that ethnicity and geography can influence a person’s molecular makeup, from metabolism and immunity to the gut microbiome and biological aging. The survey results are cell The paper, to be published on May 14, 2026, sheds light on the complex interactions between genetics and environment and provides insights for researchers and clinicians seeking to better understand healthcare in diverse populations. Preliminary findings provide new clues to further explore how a person’s ethnicity and environment influence many aspects of biology. Michael Snyder, Ph.D., Stanford W. Ascherman, MD, FACS Professor of Genetics, is…

AstraZeneca’s first foray into the PD-L1 inhibitor Imfinzi to treat bladder cancer was a huge failure. After gaining early approval for the indication in 2017, the company reluctantly regained approval four years later after a failed confirmatory trial. But since then, the company has been on a winning streak in the indication space, scoring in three Phase 3 trials. Following FDA approval for patients with muscle invasive bladder cancer (MIBC) who are eligible to receive cisplatin-based chemotherapy, AZ on Thursday reported positive Phase 3 results in patients who are not eligible for or who have refused to receive cisplatin-based chemotherapy.…

Materials scientists have designed a brain-stimulating contact lens that is as effective as Prozac in treating depression in mice. The soft, clear contact lenses contain electrodes that send gentle electrical signals through the retina to the brain, stimulating specific brain areas associated with depression. Published in Cell Press Journal on May 14, 2026 cell report physical scienceThe paper shows that after three weeks of treatment with contact lenses, depressed mice showed behavioral, neurological, and physiological signs of depression. Our research opens up a completely new frontier in treating brain diseases through the eyes. We believe this wearable, drug-free approach…

A child’s future heart health may be partially shaped before birth, reports a new Northwestern Medicine study that finds pregnancy complications are associated with poorer cardiovascular health in offspring more than 20 years later. The study found that young adults whose mothers had high blood pressure during pregnancy (either pregnancy-related hypertension, preeclampsia, or eclampsia) had more signs of early artery damage, high blood pressure, high body mass index, and high blood sugar than their peers. The authors said their study adds to growing evidence that cardiovascular risk can be transmitted across generations through a combination of biological, environmental, and behavioral…

With the FDA now rudderless with the announcement that Commissioner Marty McCully, M.D., is resigning, voices across the biopharmaceutical industry are speaking out in favor of Richard Pazdol, M.D., the FDA’s former top drug regulator, as President Donald Trump’s obvious choice to be the agency’s next commissioner. But it remains unclear whether Pazdur wants the job, despite a vote of confidence in a letter to Trump signed by more than 100 industry leaders, including pharmaceutical and biotech CEOs, partners at venture capital firms and directors of patient advocacy groups. Last month, he told Fierce that another administration would need to…

Every year, thousands of Americans develop chronic, persistent symptoms such as fatigue, cognitive impairment (“brain fog”), and other debilitating problems following acute infections with Lyme disease, COVID-19, and other pathogens. Efforts to identify the cause and develop treatments have been unsuccessful. But 16 leading researchers think they know part of the problem: research design. In the article brainResearchers from institutions such as , Rutgers University, National Institutes of Health, Rockefeller University, New York Medical College, Mount Sinai Icahn School of Medicine, Stony Brook University, and Cold Spring Harbor Laboratory argue that studies of chronic diseases related to infectious diseases are…